Atlas Trials

Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy

Clinical trial NCT02354352 · COMPLETED

Trial details

NCT number
NCT02354352
Sponsor
Ohio State University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy
Start date
2015-03-20
Primary completion
2018-05-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.